
### [MONDO:0018798](http://purl.obolibrary.org/obo/MONDO_0018798)
**Label:** other genetic dermis disorder

**Subclasses:** [MONDO:0015466](http://purl.obolibrary.org/obo/MONDO_0015466) (cranio-osteoarthropathy), [MONDO:0008172](http://purl.obolibrary.org/obo/MONDO_0008172) (PHOAD), [MONDO:0018699](http://purl.obolibrary.org/obo/MONDO_0018699) (pseudohypoparathyroidism with Albright hereditary osteodystrophy), [MONDO:0009131](http://purl.obolibrary.org/obo/MONDO_0009131) (Riley-Day syndrome), [MONDO:0008153](http://purl.obolibrary.org/obo/MONDO_0008153) (progressive osseous heteroplasia), [MONDO:0009530](http://purl.obolibrary.org/obo/MONDO_0009530) (lipoid proteinosis), [MONDO:0018168](http://purl.obolibrary.org/obo/MONDO_0018168) (primary non-essential cutis verticis gyrata), [MONDO:0008523](http://purl.obolibrary.org/obo/MONDO_0008523) (Blau syndrome), [MONDO:0015371](http://purl.obolibrary.org/obo/MONDO_0015371) (linear atrophoderma of Moulin), [MONDO:0009799](http://purl.obolibrary.org/obo/MONDO_0009799) (pachydermoperiostosis), [MONDO:0008339](http://purl.obolibrary.org/obo/MONDO_0008339) (Antecubital pterygium syndrome), [MONDO:0016071](http://purl.obolibrary.org/obo/MONDO_0016071) (juvenile hyaline fibromatosis), [MONDO:0007118](http://purl.obolibrary.org/obo/MONDO_0007118) (isolated anhidrosis with normal sweat glands), [MONDO:0007412](http://purl.obolibrary.org/obo/MONDO_0007412) (Beare-Stevenson cutis gyrata syndrome), [MONDO:0007101](http://purl.obolibrary.org/obo/MONDO_0007101) (familial primary localized cutaneous amyloidosis), [MONDO:0007078](http://purl.obolibrary.org/obo/MONDO_0007078) (Albright's hereditary osteodystrophy), [MONDO:0012912](http://purl.obolibrary.org/obo/MONDO_0012912) (pseudopseudohypoparathyroidism), [MONDO:0012911](http://purl.obolibrary.org/obo/MONDO_0012911) (pseudohypoparathyroidism type 1C), [MONDO:0013502](http://purl.obolibrary.org/obo/MONDO_0013502) (amyloidosis, primary localized cutaneous, 2), [MONDO:0009094](http://purl.obolibrary.org/obo/MONDO_0009094) (Dermochondrocorneal dystrophy), [MONDO:0013756](http://purl.obolibrary.org/obo/MONDO_0013756) (hypertrophic osteoarthropathy, primary, autosomal recessive, 2), 

**Mapped go classes:** [GO:0016404](http://purl.obolibrary.org/obo/GO_0016404) (15-hydroxyprostaglandin dehydrogenase (NAD+) activity), [GO:0015278](http://purl.obolibrary.org/obo/GO_0015278) (calcium-release channel activity), [GO:0016529](http://purl.obolibrary.org/obo/GO_0016529) (sarcoplasmic reticulum), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0033017](http://purl.obolibrary.org/obo/GO_0033017) (sarcoplasmic reticulum membrane), [GO:0006693](http://purl.obolibrary.org/obo/GO_0006693) (prostaglandin metabolic process), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0002098](http://purl.obolibrary.org/obo/GO_0002098) (tRNA wobble uridine modification), [GO:0043236](http://purl.obolibrary.org/obo/GO_0043236) (laminin binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0071361](http://purl.obolibrary.org/obo/GO_0071361) (cellular response to ethanol), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:2000404](http://purl.obolibrary.org/obo/GO_2000404) (regulation of T cell migration), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:0051537](http://purl.obolibrary.org/obo/GO_0051537) (2 iron, 2 sulfur cluster binding), [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0015132](http://purl.obolibrary.org/obo/GO_0015132) (prostaglandin transmembrane transporter activity), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0097070](http://purl.obolibrary.org/obo/GO_0097070) (ductus arteriosus closure), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0002067](http://purl.obolibrary.org/obo/GO_0002067) (glandular epithelial cell differentiation), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:0043252](http://purl.obolibrary.org/obo/GO_0043252) (sodium-independent organic anion transport), [GO:0070588](http://purl.obolibrary.org/obo/GO_0070588) (calcium ion transmembrane transport), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0031214](http://purl.obolibrary.org/obo/GO_0031214) (biomineral tissue development), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0035091](http://purl.obolibrary.org/obo/GO_0035091) (phosphatidylinositol binding), [GO:0005220](http://purl.obolibrary.org/obo/GO_0005220) (inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity), [GO:1901532](http://purl.obolibrary.org/obo/GO_1901532) (regulation of hematopoietic progenitor cell differentiation), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:1901534](http://purl.obolibrary.org/obo/GO_1901534) (positive regulation of hematopoietic progenitor cell differentiation), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0005216](http://purl.obolibrary.org/obo/GO_0005216) (ion channel activity), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004924](http://purl.obolibrary.org/obo/GO_0004924) (oncostatin-M receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0033588](http://purl.obolibrary.org/obo/GO_0033588) (Elongator holoenzyme complex), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0061371](http://purl.obolibrary.org/obo/GO_0061371) (determination of heart left/right asymmetry), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0008543](http://purl.obolibrary.org/obo/GO_0008543) (fibroblast growth factor receptor signaling pathway), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0030502](http://purl.obolibrary.org/obo/GO_0030502) (negative regulation of bone mineralization), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0002438](http://purl.obolibrary.org/obo/GO_0002438) (acute inflammatory response to antigenic stimulus), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0051209](http://purl.obolibrary.org/obo/GO_0051209) (release of sequestered calcium ion into cytosol), [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0070403](http://purl.obolibrary.org/obo/GO_0070403) (NAD+ binding), [GO:0030500](http://purl.obolibrary.org/obo/GO_0030500) (regulation of bone mineralization), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0015347](http://purl.obolibrary.org/obo/GO_0015347) (sodium-independent organic anion transmembrane transporter activity), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0003140](http://purl.obolibrary.org/obo/GO_0003140) (determination of left/right asymmetry in lateral mesoderm), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0098542](http://purl.obolibrary.org/obo/GO_0098542) (defense response to other organism), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0071320](http://purl.obolibrary.org/obo/GO_0071320) (cellular response to cAMP), [GO:0035745](http://purl.obolibrary.org/obo/GO_0035745) (T-helper 2 cell cytokine production), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0017134](http://purl.obolibrary.org/obo/GO_0017134) (fibroblast growth factor binding), [GO:0030851](http://purl.obolibrary.org/obo/GO_0030851) (granulocyte differentiation), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0019955](http://purl.obolibrary.org/obo/GO_0019955) (cytokine binding), [GO:0035469](http://purl.obolibrary.org/obo/GO_0035469) (determination of pancreatic left/right asymmetry), [GO:0043209](http://purl.obolibrary.org/obo/GO_0043209) (myelin sheath), [GO:0005134](http://purl.obolibrary.org/obo/GO_0005134) (interleukin-2 receptor binding), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0000993](http://purl.obolibrary.org/obo/GO_0000993) (RNA polymerase II core binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0001960](http://purl.obolibrary.org/obo/GO_0001960) (negative regulation of cytokine-mediated signaling pathway), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0005007](http://purl.obolibrary.org/obo/GO_0005007) (fibroblast growth factor-activated receptor activity), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0004957](http://purl.obolibrary.org/obo/GO_0004957) (prostaglandin E receptor activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0033278](http://purl.obolibrary.org/obo/GO_0033278) (cell proliferation in midbrain), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0071910](http://purl.obolibrary.org/obo/GO_0071910) (determination of liver left/right asymmetry), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0005262](http://purl.obolibrary.org/obo/GO_0005262) (calcium channel activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0002828](http://purl.obolibrary.org/obo/GO_0002828) (regulation of type 2 immune response), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0015732](http://purl.obolibrary.org/obo/GO_0015732) (prostaglandin transport), 

**Class expressions from DL-Learner:**

- Thing 54.79%
- [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity) 51.79%
- [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 51.79%
- [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding) 50.89%
- [GO:0071714](http://purl.obolibrary.org/obo/GO_0071714) (icosanoid transmembrane transporter activity) 50.89%
- [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding) 50.89%
- [GO:0070403](http://purl.obolibrary.org/obo/GO_0070403) (NAD+ binding) 50.89%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.89%
- [GO:0051537](http://purl.obolibrary.org/obo/GO_0051537) (2 iron, 2 sulfur cluster binding) 50.89%
- [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding) 50.89%
- [GO:0051429](http://purl.obolibrary.org/obo/GO_0051429) (corticotropin-releasing hormone receptor binding) 50.89%
- [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding) 50.89%
- [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding) 50.89%
- [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity) 50.89%
- [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity) 50.89%


